SCHEMBL4872803

SCHEMBL4872803

[CH2]c1ccc(O[Si](C)(C)CCCC)cc1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 9/20 0.34
CYP1A2 P05177 8/20 0.34
CYP2C9 P11712 8/20 0.34
CYP2C19 P33261 8/20 0.34
CYP2D6 P10635 9/20 0.33
CYP3A4 P08684 6/20 0.33
LTA4H P09960 3/20 0.32
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 2/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
NR5A1 Q13285 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8712246 0.86 THRB (0.33) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL10584058 0.83 ACHE (0.37) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL20535808 0.81 APP (0.34) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL8904260 0.81 TDP1 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4NPC1
SCHEMBL8904259 0.81 CYP2D6 (0.33) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL6585059 0.81 MGLL (0.43) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL5074489 0.81 LTA4H (0.50) CYP1A2CYP2C19CYP2D6CYP3A4LTA4H
SCHEMBL6987433 0.81 LTA4H (0.46) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL5991362 0.81 CHRNB2 (0.41) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL3128008 0.78 CYP3A4 (0.30) CYP19A1CYP1A2CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307198-A4 PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE HANWHA CHEMICAL CORP (KR) 2007-07-11 EP claimed
EP-1307198-A1 PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE HANWHA CHEMICAL CORPORATION (KR) 2003-05-07 EP claimed
WO-2001095908-A1 PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE HANWHA CHEMICAL CORPORATION (KR) 2001-12-20 WO claimed
US-7462604-B2 Hair growth promotor composition LION CORPORATION (JP) 2008-12-09 US disclosed
EP-1307198-A4 PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE HANWHA CHEMICAL CORP (KR) 2007-07-11 EP disclosed
US-20070116657-A1 Hair growth promotor composition LION CORPORATION (JP) 2007-05-24 US disclosed
EP-1671616-A1 HAIR TONIC COMPOSITION Lion Corporation (JP) 2006-06-21 EP disclosed
EP-1307198-A1 PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE HANWHA CHEMICAL CORPORATION (KR) 2003-05-07 EP disclosed
WO-2001095908-A1 PROTOBERBERINE DERIVATIVES WHICH INHIBIT ACTIVITY OF THE MITOGEN-ACTIVATED PROTEIN KINASE HANWHA CHEMICAL CORPORATION (KR) 2001-12-20 WO disclosed
EP-0540854-B1 Preparation for promoting hair growth SANSHO SEIYAKU KK (JP) 1998-01-21 EP disclosed
US-5656264-A ADMINISTERING TO THE SCALP OF THE MALE A PREPERATION CONSITING OF 6-BENZYLAMINOPURINE SANSYO SEIYAKU CO., LTD. (JP) 1997-08-12 US disclosed
EP-0540854-A2 Preparation for promoting hair growth Sansho Seiyaku Co., Ltd. (JP) 1993-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070116657-A1 Hair growth promotor composition BCOR, SPOUT1, IL36G CYP19A1 1755/4885CYP1A2 1518/4885CYP2C9 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.